Top of page

China

Region

Filters

Antengene HK$2.79 billion IPO

Davis Polk advised Antengene Corporation Limited in connection with its initial public offering and listing on the Hong Kong…

RemeGen HK$4 billion Hong Kong IPO

Davis Polk advised the underwriters in the initial public offering of RemeGen Co., Ltd. on the Hong Kong Stock Exchange and…
Back to top